Purple Biotech Ltd ADR (PPBT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2018 | 12-2017 | 06-2017 | 12-2016 | 06-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -5,180 | -13,000 | -6,010 | -12,120 | 0 |
| Depreciation Amortization | 3 | 4 | 2 | 2 | 0 |
| Other Working Capital | 1,130 | 120 | -900 | 260 | 0 |
| Other Operating Activity | 567 | 4,256 | 2,218 | 5,598 | 0 |
| Operating Cash Flow | $-3,480 | $-8,620 | $-4,690 | $-6,260 | $0 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -5 | -10 | -3 | -10 | 0 |
| Net Acquisitions | N/A | -1,730 | -1,730 | 0 | 0 |
| Other Investing Activity | -3,055 | 4,510 | 363 | -7,890 | 0 |
| Investing Cash Flow | $-3,060 | $2,770 | $-1,370 | $-7,900 | $0 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 7,970 | 2,990 | -150 | 10,420 | 0 |
| Financing Cash Flow | $7,970 | $2,990 | $-150 | $10,420 | $0 |
| Exchange Rate Effect | -10 | 40 | -8 | -50 | 0 |
| Beginning Cash Position | 3,940 | 6,750 | 6,750 | 10,550 | 0 |
| End Cash Position | 5,360 | 3,940 | 520 | 6,750 | 0 |
| Net Cash Flow | $1,410 | $-2,810 | $-6,230 | $-3,800 | $0 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,480 | -8,620 | -4,690 | -6,260 | 0 |
| Free Cash Flow | -3,480 | -8,620 | -4,690 | -6,260 | 0 |